Novacyt S.A. (CDI) (NCYT) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Aug 2018 07:00 AM
RNS
Half Year Revenue Update
26 Jul 2018 07:00 AM
RNS
Revenue update to be announced on 2 August 2018
02 Jul 2018 11:45 AM
RNS
Liquidity Agreement Update and Total Voting Rights
28 Jun 2018 07:00 AM
RNS
Acquisition of ID Business from Omega Diagnostics
19 Jun 2018 11:05 AM
RNS
Update on Unsecured Debt Facility
12 Jun 2018 11:45 AM
RNS
Replacement - Results of Annual General Meeting
12 Jun 2018 07:00 AM
RNS
Results of Annual General Meeting
05 Jun 2018 07:00 AM
RNS
Launch of New Product in Infectious Mononucleosis
01 Jun 2018 03:30 PM
RNS
Liquidity Agreement and Total Voting Rights
30 May 2018 06:30 PM
RNS
New Unsecured Debt Facility
23 May 2018 02:51 PM
RNS
Publication of Annual Report and Notice of AGM
01 May 2018 04:30 PM
RNS
Liquidity Agreement Update and Total Voting Rights
26 Apr 2018 07:00 AM
RNS
Novacyt Full Year 2017 Results
03 Apr 2018 01:30 PM
RNS
Liquidity Agreement Update and Total Voting Rights
22 Mar 2018 07:00 AM
RNS
Signing of Assay Development Contract with GenePOC
01 Mar 2018 02:59 PM
RNS
Liquidity Agreement Update and Total Voting Rights
01 Feb 2018 03:15 PM
RNS
Liquidity Agreement Update and Total Voting Rights
26 Jan 2018 09:32 AM
RNS
Notification of major holdings
24 Jan 2018 07:00 AM
RNS
NOVACYT REVENUES FULL YEAR 2017
02 Jan 2018 01:30 PM
RNS
Liquidity Agreement Update and Total Voting Rights
02 Jan 2018 07:00 AM
RNS
PLACED IN TECHNOLOGY FAST 500 EMEA AWARDS
01 Dec 2017 07:00 AM
RNS
Liquidity Agreement Update and Total Voting Rights
07 Nov 2017 12:39 PM
RNS
Notification of major holdings
07 Nov 2017 07:00 AM
RNS
FOR THE SECOND YEAR RUNNING WINS FAST 50 AWARD
02 Nov 2017 07:00 AM
RNS
SETTLEMENT AND REDEMPTION OF CONVERTIBLE BONDS
01 Nov 2017 07:00 AM
RNS
ADMISSION AND FIRST DAY OF DEALINGS ON AIM

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.

Novacyt launched on LSE in 2017 under the ticker NCYT. 

Novacyt share price launched at 61p. 

UK 100

Latest directors dealings